Comparison of Ki-67 index values between patients with operated giant prolactinomas and macroprolactinomas
Turkish Journal of Internal Medicine · 2022
DOI: 10.46310/tjim.1070094 ↗At a glance
Journal article in Turkish Journal of Internal Medicine, 2022. Written by Soner CANDER and 1 co-authors. 20 references.
Abstract (original language)
Objective
Data on whether there is a histopathological difference in cellular features as determined with Ki-67 between giant prolactinomas and smaller macroprolactinomas are not fully clear. In this study, we aimed to compare Ki-67 value between patients followed-up with diagnosis of macroprolactinoma and giant prolactinoma and operated for different reasons.
Methods
Files of 15 patients with giant prolactinomas and 16 patients with macroprolactinomas who had been operated with various indications were retrospectively evaluated. Similar number of patients were included to carry out a reasonable analysis. Patients’ demographics (age and gender), age at the time of diagnosis, tumor diameter during the diagnosis and at the last follow-up visit, initial and last PRL and Ki-67 values were compared between the groups. Ki-67 value was studied with MIB-1 monoclonal antibody method.
Results
The mean age and gender were similar between the patients with macroprolactinomas and giant prolactinomas. The mean longest tumor diameter at diagnosis was measured as 18.13±9.42 mm in the macroprolactinoma and 47.07±9.70 mm in the giant prolactinoma group (p
Cite
APA
CANDER, S., & GÜL, Ö. Ö. (2022). Comparison of Ki-67 index values between patients with operated giant prolactinomas and macroprolactinomas. Turkish Journal of Internal Medicine. https://doi.org/10.46310/tjim.1070094
Vancouver
CANDER S, GÜL ÖÖ. Comparison of Ki-67 index values between patients with operated giant prolactinomas and macroprolactinomas. Turkish Journal of Internal Medicine. 2022. doi:10.46310/tjim.1070094
BibTeX
@article{CANDER2022,
author = {CANDER, Soner and GÜL, Özen ÖZ},
title = {Comparison of Ki-67 index values between patients with operated giant prolactinomas and macroprolactinomas},
journal = {Turkish Journal of Internal Medicine},
year = {2022},
doi = {10.46310/tjim.1070094}
}
EUVIMED